Skip to main content
. 2022 Mar 28;14(3):60–69. doi: 10.4329/wjr.v14.i3.60

Table 2.

Search strategy

Electronic engineer
Search string
Pubmed ((“Renal transplant” OR “kidney transplant” OR “kidney transplantation” OR “renal transplantation”) AND (metastasis OR metastatic OR metastases OR “cancer” OR neoplasm OR “tumour” OR “cancers” OR “tumours” OR “tumor” OR “tumors” OR neoplasms OR melanoma OR PTLD OR lymphoma) AND (radiotherapy OR “radiation therapy”)) AND (“calcineurin inhibitors” OR “calcineurin inhibitor” OR CNI OR tacrolimus OR cyclosporine OR everolimus OR sirolimus OR “mTOR inhibitors” OR “mTOR-inhibitors” OR antimetabolites OR “antimetabolite”)
Web of Science ALL=(((Renal transplant) OR (kidney transplant) OR (kidney transplantation) OR (renal transplantation)) AND (metastasis OR metastatic OR metastases OR cancer OR neoplasm OR tumour OR cancers OR tumours OR tumor OR tumors OR neoplasms OR melanoma OR PTLD OR lymphoma) AND (radiotherapy OR (radiation therapy)) AND ((calcineurin inhibitors) OR (calcineurin inhibitor) OR CNI OR tacrolimus OR cyclosporine OR everolimus OR sirolimus OR (mTOR inhibitors) OR (mTOR-inhibitors) OR antimetabolites OR antimetabolite))
Scopus ((“Renal transplant” OR “kidney transplant” OR “kidney transplantation” OR “renal transplantation”) AND (metastasis OR metastatic OR metastases OR “cancer” OR neoplasm OR “tumour” OR “cancers” OR “tumours” OR “tumor” OR “tumors” OR neoplasms OR melanoma OR PTLD OR lymphoma) AND (radiotherapy OR “radiation therapy”)) AND (“calcineurin inhibitors” OR “calcineurin inhibitor” OR CNI OR tacrolimus OR cyclosporine OR everolimus OR sirolimus OR “mTOR inhibitors” OR “mTOR-inhibitors” OR antimetabolites OR “antimetabolite”)AND (LIMIT-TO (PUBYEAR, 2019) OR LIMIT-TO (PUBYEAR, 2018) OR LIMIT-TO (PUBYEAR, 2017) OR LIMIT-TO (PUBYEAR, 2016) OR LIMIT-TO (PUBYEAR, 2015) OR LIMIT-TO (PUBYEAR, 2014) OR LIMIT-TO (PUBYEAR, 2013) OR LIMIT-TO (PUBYEAR, 2012) OR LIMIT-TO (PUBYEAR, 2011) OR LIMIT-TO (PUBYEAR, 2010) OR LIMIT-TO (PUBYEAR, 2009)) AND (LIMIT-TO (LANGUAGE, "English"))

CNI: Calcineurin inhibitor; mTOR: Mammalian target of rapamycin.